Strategies for managing cardiotoxicity in patients on osimertinib are discussed, focusing on monitoring adverse events and balancing symptom management with maintaining treatment efficacy. News Latest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback